Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

ImmunoCellular Therapeutics Ltd

+ Add to Watchlist

IMUC:US

0.4834 USD 0.0034 0.71%

As of 20:04:05 ET on 05/29/2015.

Snapshot for ImmunoCellular Therapeutics Ltd (IMUC)

Open: 0.4990 Day's Range: 0.4813 - 0.4990 Volume: 223,679
Previous Close: 0.4800 52wk Range: 0.4264 - 1.4500 1-Yr Rtn: -63.93%

Stock Chart for IMUC

No chart data available.
  • IMUC:US 0.4834
  • 1D
  • 1M
  • 1Y
0.4800
Interactive IMUC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMUC

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1300
Est. EPS (USD) (12/2015) -0.2100
Est. PEG Ratio -
Market Cap (M USD) 43.63
Shares Outstanding (M) 90.25
30 Day Average Volume 580,406
Price/Book (mrq) 1.3479
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMUC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMUC

ImmunoCellular Therapeutics, Ltd. is a development stage company that seeks to develop imaging devices with medical diagnostic applications.

John S YuChairman/Chief Scientific Ofcr/SecyAndrew W GengosPresident/CEO
David E FractorVP:Finance/CFO/TreasurerAnthony J Gringeri "Tony"Senior VP:Strategic Resources
More Company Profile & Key Executives for IMUC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil